It’s a well-known fact that many diseases have a unique smell or “breathprint” providing an early indicator of the condition. Over the years we’ve heard about dogs and cats who’ve been able to detect these odors and identify illness with their keen sense of smell. Now, modern medicine is turning to a more sophisticated sniffer—an electronic nose, or eNose.
Key Takeaways
- Your breath contains hundreds of chemical clues. Disease can alter metabolism and change patterns of volatile organic compounds released in exhaled breath.
- Electronic noses use sensors and AI to recognize these patterns. Rather than looking for just one chemical, newer systems can identify complex disease-associated “breathprints.”
- Cancer research is especially promising. Researchers are studying eNoses not only for detecting certain cancers, but also for the possibility of monitoring how patients respond to treatment.
Your Breath May Reveal More About Your Health Than You Think
Whether it’s asthma, Alzheimer’s disease, COVID-19 or cancer, eNoses offer a powerful, fast, non-invasive approach to diagnose illness. They also have applications in the screening, prognosis, and treatment of disease. Let’s take a closer look. Exhaled breath contains thousands of microscopic aerosol particles and volatile organic compounds (VOCs).
These, as we know with COVID-19 and other respiratory illnesses, can spread disease. But what you may not know is that VOCs in breath are also associated with biochemical and metabolic processes and become altered during abnormal cellular activity, giving a specific disease signature. Although this VOC alteration has been recognized since the 1970s, the technology didn't exist to take advantage of this knowledge. But with advances in computational analysis and the application of machine learning, this has changed, and is reflected in the explosion of research over the last two decades.
“Will Guide Future Treatment in Oncology”
Cancer is where some of the most exciting eNose research is taking place.
In 2026, researchers published one of the most comprehensive analyses of the technology to date. They reviewed 37 studies involving 1,365 cancer patients and 2,249 people without cancer, covering six different cancers: breast, colorectal, gastric, lung, ovarian and prostate.
The results were impressive.
Overall, electronic noses detected cancer with a sensitivity of nearly 86 percent and a specificity of almost 84 percent. For most of the individual cancers studied, both measures hovered around 85 percent.
Lung cancer has produced particularly encouraging results. A separate systematic review and meta-analysis encompassing 35 studies and 4,483 patients found that electronic noses detected lung cancer with 90 percent sensitivity and 89 percent specificity.
But scientists are looking beyond simply detecting cancer.
Researchers at Memorial Sloan Kettering Cancer Center are now conducting a Phase II clinical trial to determine whether changes in a patient's unique "breathprint" can reveal how well non-small cell lung cancer is responding to treatment.
Patients breathe into a collection device before and after treatment. Researchers then analyze changes in volatile organic compounds, or VOCs, and compare them with tumor response.
This raises an intriguing possibility: Someday, doctors may be able to use a simple, noninvasive breath test not only to help detect cancer, but also to monitor how well treatment is working.
That's a remarkable leap for a technology that essentially gives a computer a sense of smell.
Could Your Breath Reveal Changes in the Brain?
Cancer isn't the only disease that appears to leave a chemical fingerprint behind.
Researchers have also discovered differences in volatile organic compounds in the breath of people with Alzheimer's disease compared with healthy adults.
In an earlier pilot study involving 100 people, researchers were able to distinguish between healthy adults and those with Alzheimer's disease with 83 percent accuracy.
More recent research continues to explore disease-specific breath profiles for neurological disorders including Alzheimer's and Parkinson's disease.
But unlike some of the more advanced cancer research, electronic-nose testing for Alzheimer's remains experimental. Larger clinical studies are needed before doctors can rely on a breath test to diagnose the disease.
Even so, the possibility is fascinating: Changes taking place deep inside the brain may ultimately leave detectable chemical clues in something as simple as the air you breathe out.
Artificial Intelligence Gives the Electronic Nose a Boost
There's another reason electronic noses are becoming more sophisticated: artificial intelligence.
A single breath can contain hundreds of different volatile organic compounds. Instead of searching for just one chemical linked to a disease, newer eNose systems use arrays of sensors combined with machine-learning algorithms to recognize complex patterns among these compounds.
In effect, the sensors act as the nose while artificial intelligence helps act as the brain—learning to recognize a chemical "breathprint" associated with a particular condition.
Advances in machine learning, sensor technology and data processing are now helping researchers develop smaller, smarter and potentially more accurate eNose systems.
Researchers still have important hurdles to overcome, including standardizing breath collection, preventing sensor drift and proving that results remain accurate across large and diverse populations.
But the technology has advanced considerably from the early experimental devices researchers were testing just a few years ago.
From Science Fiction to the Doctor's Office?
Electronic noses aren't ready to replace blood tests, biopsies, imaging or other established diagnostic tools.
But they're getting closer to becoming useful partners to them.
The attraction is obvious. Breath collection is fast, painless and noninvasive. And because disease can alter metabolism—and therefore the volatile compounds released by the body—a person's breath may contain an extraordinary amount of information about what's happening inside.
Researchers are investigating eNoses for cancer, respiratory disorders, neurological diseases and other conditions. They're even studying whether changes in a person's breathprint can reveal whether cancer treatment is working.
The technology still needs larger clinical studies, standardized testing methods and validation across different populations before it becomes part of routine medical care.
But the basic idea no longer seems quite so futuristic.
One day, detecting signs of disease really could begin with something as simple as taking a breath.
Summary
Scientists are developing electronic noses, or eNoses, capable of detecting patterns of volatile organic compounds (VOCs) released in human breath. Because disease can alter metabolism and the chemicals the body produces, these compounds may create distinctive “breathprints” associated with certain illnesses. Researchers are studying the technology for conditions ranging from cancer to neurological disease, with particularly promising results emerging from cancer research. Newer systems combine sophisticated sensor arrays with artificial intelligence and machine learning to identify complex chemical patterns. Although eNoses are not yet replacements for established diagnostic tests, researchers are investigating whether these fast, painless and noninvasive devices could eventually help detect disease and even monitor treatment response.
Frequently Asked Questions
What is an electronic nose?
An electronic nose, or eNose, is a device containing sensors designed to detect patterns of volatile organic compounds. Computer algorithms can then analyze those patterns for signatures associated with particular conditions.
How can disease change the smell of your breath?
Diseases can alter metabolic and cellular processes in the body. These changes may affect the VOCs released into the bloodstream and ultimately exhaled through the lungs.
Can an electronic nose detect cancer?
Research suggests eNoses can distinguish VOC patterns associated with several cancers, with particularly active research involving lung cancer. However, these devices are still being studied and aren't replacements for established cancer screening or diagnostic tests.
Can breath tests detect Alzheimer’s disease?
Researchers have found differences in breath VOC patterns between people with Alzheimer’s disease and healthy individuals. However, eNose testing for Alzheimer's remains experimental and requires further clinical validation.
Are electronic noses currently used by doctors?
The technology is being investigated in clinical research, but eNoses aren't yet a routine replacement for established diagnostic tools. Researchers are working to improve accuracy, standardization and validation across different populations.
